Paul Richardson
MD
Clinical Program Leader and Director of Clinical Research, Jerome Lipper Multiple Myeloma Center
👥Biography 个人简介
Paul Richardson is a pioneering myeloma clinician-scientist who has led the development of multiple classes of myeloma therapies. His contributions span proteasome inhibitors, IMiDs, and now bispecific antibodies, with involvement in key registration trials. He has been instrumental in defining combination strategies incorporating bispecific antibodies for relapsed/refractory myeloma.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Paul Richardson 的研究动态
Follow Paul Richardson's research updates
留下邮箱，当我们发布与 Paul Richardson（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment